- $605.38m
- $422.26m
Brief: Eliem Therapeutics Says Formed Special Committee Of Independent & Disinterested Directors To Oversee Co's Exploration Of Strategic Alternatives
U.S. STOCKS ON THE MOVE-Zions, Intuitive Surgical, Johnson & Johnson
U.S. STOCKS ON THE MOVE-Microsoft, copper miners, medical device makers
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Catalent, Whirlpool
Eliem Therapeutics rises on exploring strategic options
Brief: Eliem Therapeutics Announces Plans To Explore Strategic Alternatives
Brief: Eliem Therapeutics Reports First Quarter Financial Results
Brief: Eliem Therapeutics Says Erin Lavelle Would Resign As COO And CFO
Brief: Eliem Therapeutics Reports Fourth Quarter And Year-End Financial Results
U.S. STOCKS ON THE MOVE-Ralph Lauren, J.M. Smucker, Lions Gate
U.S. STOCKS ON THE MOVE-Silvergate Capital, PayPal, Spotify
Eliem Therapeutics falls on pausing development of depression drug
Brief: Eliem Therapeutics Provides Strategic Update, Announces Leadership Transition
Brief: Eliem Therapeutics Reports Q3 Loss Of $0.37 Per Share
Brief: Eliem Therapeutics Provides Update On Pipeline Progress
U.S. RESEARCH ROUNDUP- Aptinyx, Rapid Micro Biosystems, Trinet Group
Brief: Eliem Therapeutics Inc Reports Cash, Cash Equivalents And Short- And Long-Term Marketable Securities Was $134.7 Million As Of June 30, 2022
U.S. STOCKS ON THE MOVE-Repligen, Tesla, Harmony Biosciences
U.S. STOCKS ON THE MOVE-Arista Networks, Innoviz, JetBlue